Literature DB >> 15140837

Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF19)?

Alison M Strack, Robert W Myers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15140837     DOI： 10.1210/en.2004-0367

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  7 in total

1.  Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho.

Authors:  Masao Nakamura; Yuriko Uehara; Masahiro Asada; Emi Honda; Naoko Nagai; Koji Kimata; Masashi Suzuki; Toru Imamura
Journal:  J Biol Chem       Date:  2011-06-08       Impact factor: 5.157

Review 2.  Farnesoid x receptor agonists: what they are and how they might be used in treating liver disease.

Authors:  Brent A Neuschwander-Tetri
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 3.  The FGF family: biology, pathophysiology and therapy.

Authors:  Andrew Beenken; Moosa Mohammadi
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

4.  Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats.

Authors:  Karen K Ryan; Rohit Kohli; Ruth Gutierrez-Aguilar; Shrawan G Gaitonde; Stephen C Woods; Randy J Seeley
Journal:  Endocrinology       Date:  2012-11-26       Impact factor: 4.736

5.  Bile Acid and Fibroblast Growth Factor 19 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Sleeve Gastrectomy.

Authors:  Hsien-Hao Huang; Wei-Jei Lee; Shu-Chun Chen; Tung-Fang Chen; Shou-Dong Lee; Chih-Yen Chen
Journal:  J Clin Med       Date:  2019-06-07       Impact factor: 4.241

Review 6.  Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors.

Authors:  Harold Bays; Peter H Jones
Journal:  Vasc Health Risk Manag       Date:  2007

7.  Serum levels of fibroblast growth factor 19 are inversely associated with coronary artery disease in chinese individuals.

Authors:  Yaping Hao; Jian Zhou; Mi Zhou; Xiaojing Ma; Zhigang Lu; Meifang Gao; Xiaoping Pan; Junling Tang; Yuqian Bao; Weiping Jia
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.